GliaPharm SA

GliaPharm is a Swiss biotechnology company that develops treatments for neurological and psychiatric disorders.

GliaPharm’s innovative therapeutic approach is to target glial cells, the ‘support cells’ of neurons, to sustain their function and survival, and enhance brain metabolism in pathological conditions. We aim at developing new drugs that target glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.